RESOURCES

Blogs

Insight at the intersection of data science and real-world health

The Talking Room

Demystifying AI, LLMs and machine learning

Use Cases

How teams put the signals to work

Compliance Hub

Data integrity, ethical AI and regulatory standards

DrugVoice

Built to be defensible.

Compliance, ethics, and data integrity are part of the process.

TMLABS

About us

Where our proprietary models are trained, tested and refined

Articles & scientific publications

Peer-reviewed methodologies and validated outcomes

Latest paper

The New GLP-1 Consumer

Articles & Scientific Publications

DRUGVOICE

DrugVoice

Measure how your messaging lands and evidence what moved

SEE IT IN ACTION

Bring us a question you can’t answer.

We’ll show you what the conversation already contains, using your therapy area and your audience.

ABOUT US

About us

Where our proprietary models are trained, tested and refined

ESG

Responsible innovation and ethical data practice

WHO WE ARE

Data scientists who speak pharma.

A team built around one problem: making real-world conversation usable at scale.

ESG and Impact

Talking Medicines social mission is to improve Patient outcomes. We believe that this can be achieved through the provision of gold standard, real-world, Patient experience data, by medicine. This actionable intelligence will drive more effective Patient care and support

Talking Medicines approaches this through our innovative approach to ‘Data for Good’

Culture, Innovation, Transparency, and Quality are woven into our working culture, and are evidenced in our approach to ESG and Impact

Our Core Values

“Environmental, Social, Governance (known as ESG) isn’t just a tick box for us. We believe in profit for purpose and our goal is creating better health outcomes for Patients and People. It’s a commitment that runs through everything we do.”

Scott Crae

Founder | Partnerships, ESG and Impact

Our Seven Pillars of ESG and Impact

#
$

People

Our people play a crucial part in shaping our social responsibility, fostering a diverse and inclusive culture, and driving ethical business practices

Our ESG strategy is esssential for attracting top talent to ensure long-term resilience and positive societal impact

Innovation

We place great importance in using innovative approaches in our business and in our AI to drive true commercial and societal benefit

By prioritizing ESG factors we believe we are driving innovation that addresses global and social challenges

Community

We aspire to contribute positively to our communities, thereby aligning with the evolving expectations of stakeholders and investors.

We are constantly learning from and fortunate to benefit from the experience of others to refine our practices and operations as well as giving back to take others forward

Environment

Talking Medicines prioritizes environmental responsibility to contribute toward sustainability and mitigate climate risks. We also aim to align with the growing awareness of eco-conscious practices alongside our stakeholder partners

We recognize the importance of good environmental practice and understand that it is crucial for ethical business conduct

Finance

Integrating finance into our ESG framework enhances our corporate reputation and attracts socially responsible investors and partners, fostering sustainable and responsible business practices

Governance

Strong governance practices not only safeguard against potential risks but also ensure transparent communication with stakeholders, reinforcing the company’s commitment to social responsibility

Effective governance is integral to building resilience, maintaining trust, and fostering sustainable business practices

Impact

Impact refers to the measurable and often transformative effects that an action, initiative, or entity has on various aspects of society, the environment, or the economy

Talking Medicines have a strategy on social impact that includes the key team, community, and stakeholder partners including Patients and Patient organisations

Get in Touch

Start the conversation and see how unstructured data can become actionable intelligence